Tags » Technology Commercialization

Startup profile: ApoGen Biotechnologies

ApoGen Biotechnologies Inc. is developing new drug therapies that will make cancer treatments more effective. The company is based on scientific discoveries by the University of Minnesota’s Reuben Harris, Ph.D., professor of biochemistry, molecular biology and biophysics, and Daniel Harki, Ph.D., assistant professor of medicinal chemistry. 559 more words


Startup profile: Reflection Sciences

Reflection Sciences, launched in July 2014, provides training and tools for assessing executive function skills in early childhood. The company is based on the Minnesota Executive Function Scale, technology developed by Professors Philip Zelazo and Stephanie Carlson of the University of Minnesota’s Institute of Child Development. 514 more words


Patent roll call, fall 2014

Patents allow the most promising discoveries of today to become the game-changing innovations of tomorrow. A key milestone in the transition from the lab to the marketplace, patents protect the ownership of university technologies and grant them real-world applications to benefit society. 501 more words